WeVote

Bill

Bill

HB 263

AN ACT relating to undesignated glucagon.

2026 Regular Session Introduced by Matt Lehman and 1 co-sponsor

HB 263 likely permits broader public access to undesignated glucagon emergency medication for hypoglycemia treatment without individual prescriptions, similar to naloxone policies.

to Health Services (H)
0

WeVote — Public opinion

No community votes yet. Be the first to weigh in from the Vote tab.

Bill text & amendments

No documents yet

The official bill text and any amendments will be posted here once available.